Zhejiang CONBA Pharmaceutical Co Ltd (600572) - Total Liabilities

Latest as of September 2025: CN¥2.97 Billion CNY ≈ $434.89 Million USD

Based on the latest financial reports, Zhejiang CONBA Pharmaceutical Co Ltd (600572) has total liabilities worth CN¥2.97 Billion CNY (≈ $434.89 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how efficiently does Zhejiang CONBA Pharmaceutical Co Ltd generate cash to assess how effectively this company generates cash.

Zhejiang CONBA Pharmaceutical Co Ltd - Total Liabilities Trend (2001–2024)

This chart illustrates how Zhejiang CONBA Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Check asset resilience ratio of Zhejiang CONBA Pharmaceutical Co Ltd to evaluate the company's liquid asset resilience ratio.

Zhejiang CONBA Pharmaceutical Co Ltd Competitors by Total Liabilities

The table below lists competitors of Zhejiang CONBA Pharmaceutical Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
PLUXEE NV PA:PLX	France	€5.93 Billion
Qingdao Gaoce Technology Co Ltd SHG:688556	China	CN¥3.84 Billion
Yunnan Salt & Salt Chemical Industry Co Ltd SHE:002053	China	CN¥8.40 Billion
Makalot Industrial Co Ltd TW:1477	Taiwan	NT$8.93 Billion
Mister Car Wash, Inc. Common Stock NYSE:MCW	USA	$2.04 Billion
Choice International Limited NSE:CHOICEIN	India	Rs14.80 Billion
Metrics Master Income Trust AU:MXT	Australia	AU$16.75 Million
Fagron NV BR:FAGR	Belgium	€686.87 Million

Liability Composition Analysis (2001–2024)

This chart breaks down Zhejiang CONBA Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Zhejiang CONBA Pharmaceutical Co Ltd market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.83	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.42	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.29	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Zhejiang CONBA Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Zhejiang CONBA Pharmaceutical Co Ltd (2001–2024)

The table below shows the annual total liabilities of Zhejiang CONBA Pharmaceutical Co Ltd from 2001 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥2.99 Billion ≈ $437.40 Million	-23.13%
2023-12-31	CN¥3.89 Billion ≈ $569.02 Million	+7.84%
2022-12-31	CN¥3.61 Billion ≈ $527.66 Million	+6.04%
2021-12-31	CN¥3.40 Billion ≈ $497.61 Million	-13.45%
2020-12-31	CN¥3.93 Billion ≈ $574.96 Million	-20.10%
2019-12-31	CN¥4.92 Billion ≈ $719.60 Million	-0.06%
2018-12-31	CN¥4.92 Billion ≈ $720.07 Million	+37.59%
2017-12-31	CN¥3.58 Billion ≈ $523.36 Million	-10.74%
2016-12-31	CN¥4.01 Billion ≈ $586.35 Million	-19.92%
2015-12-31	CN¥5.00 Billion ≈ $732.16 Million	+70.85%
2014-12-31	CN¥2.93 Billion ≈ $428.55 Million	+57.26%
2013-12-31	CN¥1.86 Billion ≈ $272.52 Million	-11.23%
2012-12-31	CN¥2.10 Billion ≈ $307.01 Million	+55.60%
2011-12-31	CN¥1.35 Billion ≈ $197.30 Million	+80.42%
2010-12-31	CN¥747.34 Million ≈ $109.36 Million	-4.28%
2009-12-31	CN¥780.76 Million ≈ $114.25 Million	+20.19%
2008-12-31	CN¥649.60 Million ≈ $95.06 Million	-6.31%
2007-12-31	CN¥693.32 Million ≈ $101.45 Million	+10.37%
2006-12-31	CN¥628.20 Million ≈ $91.93 Million	+12.07%
2005-12-31	CN¥560.55 Million ≈ $82.03 Million	+34.63%
2004-12-31	CN¥416.37 Million ≈ $60.93 Million	+21.67%
2003-12-31	CN¥342.22 Million ≈ $50.08 Million	+30.68%
2002-12-31	CN¥261.88 Million ≈ $38.32 Million	-1.45%
2001-12-31	CN¥265.74 Million ≈ $38.89 Million	--

About Zhejiang CONBA Pharmaceutical Co Ltd

SHG:600572 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.65 Billion

CN¥11.29 Billion CNY

Market Cap Rank

#7028 Global

#1646 in China

Share Price

CN¥4.45

Change (1 day)

-0.67%

52-Week Range

CN¥4.06 - CN¥4.94

All Time High

CN¥10.42